ClinVar Miner

Submissions for variant NM_000038.6(APC):c.1744-3T>C

gnomAD frequency: 0.00001  dbSNP: rs760166803
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Color Diagnostics, LLC DBA Color Health RCV000583077 SCV000686853 uncertain significance Hereditary cancer-predisposing syndrome 2021-07-29 criteria provided, single submitter clinical testing This variant causes a T to C nucleotide substitution at the -3 position of intron 14 of the APC gene. To our knowledge, functional studies have not been reported for this variant. This variant has not been reported in individuals affected with hereditary cancer in the literature. This variant has been identified in 1/251084 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance.
GeneDx RCV000826981 SCV000968587 likely benign not provided 2018-06-11 criteria provided, single submitter clinical testing This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.
Invitae RCV002232694 SCV001377709 likely benign Familial adenomatous polyposis 1 2023-07-17 criteria provided, single submitter clinical testing
Ambry Genetics RCV000583077 SCV002711580 uncertain significance Hereditary cancer-predisposing syndrome 2021-10-28 criteria provided, single submitter clinical testing The c.1744-3T>C intronic variant results from a T to C substitution 3 nucleotides upstream from coding exon 14 in the APC gene. This nucleotide position is not well conserved in available vertebrate species. In silico splice site analysis predicts that this alteration will not have any significant effect on splicing. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.